These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [MULTISTRATEGY and FATA: merits, limits and troubles of no profit clinical trials in acute myocardial infarction]. Savonitto S G Ital Cardiol (Rome); 2009 Jun; 10(6):364-5. PubMed ID: 19603607 [No Abstract] [Full Text] [Related]
30. Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials. Navarese EP; Kozinski M; Obonska K; Margheri M; Gurbel PA; Kubica J; De Luca G Platelets; 2012; 23(4):274-81. PubMed ID: 21988317 [TBL] [Abstract][Full Text] [Related]
31. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466 [TBL] [Abstract][Full Text] [Related]
32. [The early management of ST-elevation acute myocardial infarction in the Lombardy Region (GestIMA)]. Oltrona L; Mafrici A; Marzegalli M; Fiorentini C; Pirola R; Vincenti A; Ital Heart J Suppl; 2005 Aug; 6(8):489-97. PubMed ID: 16161503 [TBL] [Abstract][Full Text] [Related]
33. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Mehta SR; J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860 [TBL] [Abstract][Full Text] [Related]
34. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence. Singh S; Gopal AK; Bahl VK Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176 [No Abstract] [Full Text] [Related]
35. Facilitated PCI: crossing the bridge with lessons learned. Mishra S; Bahl VK Indian Heart J; 2009; 61(5):410-2. PubMed ID: 20635753 [No Abstract] [Full Text] [Related]
36. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation. Tornvall P; Nilsson T; Lagerqvist B J Intern Med; 2006 Oct; 260(4):363-8. PubMed ID: 16961673 [TBL] [Abstract][Full Text] [Related]
37. No reflow and the quest to achieve optimal perfusion during the acute phase of myocardial infarction. Chaitman BR; Lim MJ J Am Coll Cardiol; 2004 Jul; 44(2):313-5. PubMed ID: 15261924 [No Abstract] [Full Text] [Related]
39. [Primary coronary angioplasty for myocardial infarction--the view of the cardiologic surgeon]. Tabone X Ann Cardiol Angeiol (Paris); 2012 Nov; 61(5):352-6. PubMed ID: 23098611 [TBL] [Abstract][Full Text] [Related]
40. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J; 1996 Jan; 17(1):43-63. PubMed ID: 8682130 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]